Advanced Magnetics, Inc. to Present at The Morgan Stanley Global Healthcare Unplugged Conference

CAMBRIDGE, Mass., April 24 /PRNewswire-FirstCall/ -- Advanced Magnetics, Inc. , today announced that it will participate in Morgan Stanley's Global Healthcare Unplugged conference, being held May 2 - 4, 2007 in Key Biscayne, Florida. Brian J.G. Pereira, MD, President and Chief Executive Officer of Advanced Magnetics, will present a brief overview of the company on Thursday, May 3, at 12:45 pm ET. This will be followed by an approximate thirty-minute question and answer session, moderated by a Morgan Stanley analyst, during which Dr. Pereira will address and discuss Advanced Magnetics' activities and milestones with the investor audience.

A live webcast of this event will be accessible through the Investors section of the company's website at www.advancedmagnetics.com. The event will also be archived on the Advanced Magnetics website for a limited period of time following the conference.

About Advanced Magnetics

Advanced Magnetics, Inc. is a developer of superparamagnetic iron oxide nanoparticles used in pharmaceutical products. As a leader in our field, we are dedicated to the development and commercialization of our proprietary nanoparticle technology for use in therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Ferumoxytol, the company's key product candidate, is in Phase III clinical development as an intravenous (IV) iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. The company plans to file a New Drug Application for marketing approval of ferumoxytol with the U.S. Food and Drug Administration during the fourth calendar quarter of 2007.

Combidex(R), the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with MRI to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.

Contact: Kristen Galfetti kgalfetti@advancedmagnetics.com (617)498-3362

Advanced Magnetics, Inc.

CONTACT: Kristen Galfetti of Advanced Magnetics, Inc., +1-617-498-3362,kgalfetti@advancedmagnetics.com

MORE ON THIS TOPIC